Piper Sandler Upgrades Zimmer Biomet Holdings to Overweight
Piper Sandler analyst Matt O'Brien upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Neutral to Overweight.
Fear & Greed Index Remains In ‘Greed’ Zone As Nasdaq Record Sharp Gains For Fourth Straight Week
The CNN Money Fear and Greed index showed some decline in overall sentiment among US investors.
US stocks closed mostly higher on Thursday, with the tech-laden Nasdaq index leading the rally.
Investors digested the Fed's policy decision and comments from Federal Reserve Chair Jerome Powell on Wednesday.
RBC Capital Upgrades Zimmer Biomet Holdings to Outperform, Raises Price Target to $141
RBC Capital analyst Shagun Singh upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Sector Perform to Outperform and raises the price target from $125 to $141.
Morgan Stanley Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $135
Morgan Stanley analyst Cecilia Furlong maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $120 to $135.
Congressman Sells Stocks At End Of 2022 And Retires From Office: Taking Profits Or Warning Sign?
A member of Congress sold out of his positions of several stocks at the end of 2022. The move came as he finished his term serving the state of Texas and announced his retirement.
Congressional Trading Report: Rep. Nicholas V. Taylor Sold Over $100K In Zimmer Biomet Holdings Stock
Nicholas V. Taylor, a Representative from Texas, reported a sale of Zimmer Biomet Holdings (NYSE:ZBH) stock on December…
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $135
Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $120 to $135.
6 Analysts Have This to Say About Zimmer Biomet Holdings
Within the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…
RBC Capital Maintains Sector Perform on Zimmer Biomet Holdings, Lowers Price Target to $125
RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Sector Perform and lowers the price target from $128 to $125.
Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $116
Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $119 to $116.